Member Info for Rcdm

Slow meander to around 380-400 for me with some contract news is it from this 'new' base.

which laughably is around 15% lower than the base pre DHSC contract news and everyone loaded up!

From the trends and the last month or so of market activities it looks like its being pegged back. Interestingly its still not up at 172, which was its January 2021 pricing with in my view, less prospects, so its still not hugely and widely loved investment wise.

Love this. Typical AIM chat. A few weeks ago this was scrapping 130 odds and was pants. Today its what colour is my ferrari.

This will either awaken on positive news in the coming months or be stale and mouldy. I think DA must know that a better performance is needed in the stock market engagement and im hopeful this will mature.

It was more positive than negative but still work to do to pick investor confidence.

Id imagine a cheery RNS post 18th Oct will say ta ta to the algo bot garbage with some solid and quality news on the direction of this rudderless business.

Interesting mix, assessing the actual comments on sentiment it seems more downbeat than upbeat. A sad but accurate reflection of investor confidence in this matter.

Positive. Hold tight

Ok so what chances do you give £5 or higher in next 3-6months.

Lets see the mood on the board.

For me the lack of comms has been definitely below par. However the longer term view of this is interesting. Around this time last year with the market viewing NCYT as an innovative and leader at the forefront of diagnostics we headed right into UK's lockdown 2 and the world was dizzy looking for answers. The SP was pushing and surging in a fashion that testing was part of the world solution to answering how society would open up.

This confidence and the 'load' on NCYT saw it in Oct become an incredible performer. This shows the world viewed testing as high on agenda. The business was well placed. That is still evident.

Where things for me have went wrong has been completely overplayed but only hampered by an ill mouthed BOD and also a lack of 'respect' some feel for shareholders.

In January, the 25th, to be precise this was in a good shape. It feel down after that however, the RNS at that time showed that (after the vaccine news in Nov) that the world was shifting, society WOULD reopen and testing as an investment was now second pony to vaccines and that there was mass competition.

To me the NCYT position at £10-12 was justified, at the time, but not long term sustainable as the 2021 position wouldnt 'last forever'. The gradual erosion to around £7-8 was therefore incoming. The BOD were panned at that stage and there was extensions this/ that the other being spoke over.

Mullins ended everyones 'huge' (pinch of salt) profits with the crude friday RNS In the April. Timing was rubbish but the giddy tone went and in fairness 440p that day was seen as an over reaction.

It rebounded to 515p from memory and everyone thought it would shake off, but then May society opened, DHSC issues rumbled and confidence went. It continued to go as taking on board that 2021 was seen as NCYTs swansong that 22 was always a bit dubious if covid PCR's and systems were less required in society (if perhaps in my eyes a dimwhitted view).

Now where it went was typical AIM. Shorters paradise. Lots of utter garbage on here and tonnes of dickswing posts, ramp this, deramp that and alot of noise over egos and garbage. The reality was that 440p was utopian.

It has never eclipsed 440p in april (in all reality) and in the recent 'good news' in August it looked like it would rest there but alas it didnt as the market didnt fancy it and for me NCYT thought it was time to clear out all the poor news hence the last RNS's have been doing exactly that.

So I had said in my eyes it would rest at 380-400 as a 'true value'. I stil believe that is true.

The current pantomine is precisely that. Its a demoralisin share that last October was the golden ticket but this year is a rotten apple. Its covid and its here to stay but the world has arisen and has solutions. Its up to NCYT whether this new chapter will see a broadly sustainable part to play in how we all 'live with covid' and exist.

I am still more glass half full. This share has tested resolve and is an

Certainty this will be £10 post the AGM then if FM's track record of reporting is anything to go off.

Platform is there

Positive but frustrating in equal measure, we dont have a fixed date!

Shaping up for in ten days time to be into the range of 350-375 for me.

Not investment advice!!!

Covidopportunist - pre Government the price was 295p. So we are scrapping the barrel.

The reason it catapulted last September was the Government you are right but to state its £1 without is just garbage.

So another slap in the face day, one we have become too familiar with.

But wider field of vision, whats the next steps and whats known?
- 27/09/21 reveals results. Id expected a buoyant tone
- CEO on board with a fairly robust history
- DHSC rumbles on, but has been completely done to death
- Sales update into 4Q '21 and no doubt the LFT news/ USA market pick ups.

Think you can bat on the negatives and positives here, but despite the doom here, I do feel 380-400 is the best outlook but will be bolstered by a better and more coherent PI comms strategy and ideally 'good news' contract wins being revealed.

Bit of star gazing and this may actually drag over 400s and upwards again I feel.

Any views?

DYOR!!

Yes 27th is symbolic and id imagine that will aid a small recovery from where this is plunging to.

Im still sticking with my 380-400 valuation til DHSC is resolved.

Good side:- nunbers disclosed and clean slate
Bad news:- its not a staunch investment and the dispute proves so.

Overall low investor confidence. Sp in freefall again.

Investor confidence here has been rattled and BOD didnt really offer any lifeline to support. The reality is the company on paper looks good but has been shocking in stock/ shareholder mgt.

The whole episode over DHSC is the anchor to everything that a shorter needs to suceed and hence this stock is cannon fodder for that nature of investor.

Will it recover, how will it recover, who knows. Any big results on AGM will soothe I feel and push things on, however the ramp will plateau unless a shrewd hardy CEO stems the uncertainty with a robust and confident stance to secure investment and longevity.

Interesting reading. Feel the news pending is going to see 200 becoming a base